[English] 日本語
Yorodumi- EMDB-27081: IMM20184 and IMM20253 Fabs in ternary complex with SARS-CoV-2 rec... -
+Open data
-Basic information
Entry | Database: EMDB / ID: EMD-27081 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Title | IMM20184 and IMM20253 Fabs in ternary complex with SARS-CoV-2 receptor binding domain | |||||||||
Map data | IMM20184 and IMM20253 Fabs in complex with SARS-CoV-2 receptor binding domain | |||||||||
Sample |
| |||||||||
Biological species | Severe acute respiratory syndrome coronavirus / Homo sapiens (human) | |||||||||
Method | single particle reconstruction / cryo EM / Resolution: 4.0 Å | |||||||||
Authors | Robinson MK / Nikitin PN | |||||||||
Funding support | United States, 1 items
| |||||||||
Citation | Journal: Sci Immunol / Year: 2022 Title: IMM-BCP-01, a patient-derived anti-SARS-CoV-2 antibody cocktail, is active across variants of concern including Omicron BA.1 and BA.2. Authors: Pavel A Nikitin / Jillian M DiMuzio / John P Dowling / Nirja B Patel / Jamie L Bingaman-Steele / Baron C Heimbach / Noeleya Henriquez / Chris Nicolescu / Antonio Polley / Eden L Sikorski / ...Authors: Pavel A Nikitin / Jillian M DiMuzio / John P Dowling / Nirja B Patel / Jamie L Bingaman-Steele / Baron C Heimbach / Noeleya Henriquez / Chris Nicolescu / Antonio Polley / Eden L Sikorski / Raymond J Howanski / Mitchell Nath / Halley Shukla / Suzanne M Scheaffer / James P Finn / Li-Fang Liang / Todd Smith / Nadia Storm / Lindsay G A McKay / Rebecca I Johnson / Lauren E Malsick / Anna N Honko / Anthony Griffiths / Michael S Diamond / Purnanand Sarma / Dennis H Geising / Michael J Morin / Matthew K Robinson / Abstract: Monoclonal antibodies are an efficacious therapy against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, rapid viral mutagenesis led to escape from most of these therapies, ...Monoclonal antibodies are an efficacious therapy against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, rapid viral mutagenesis led to escape from most of these therapies, outlining the need for an antibody cocktail with a broad neutralizing potency. Using an unbiased interrogation of the memory B cell repertoire of patients with convalescent COVID-19, we identified human antibodies with broad antiviral activity in vitro and efficacy in vivo against all tested SARS-CoV-2 variants of concern, including Delta and Omicron BA.1 and BA.2. Here, we describe an antibody cocktail, IMM-BCP-01, that consists of three patient-derived broadly neutralizing antibodies directed at nonoverlapping surfaces on the SARS-CoV-2 Spike protein. Two antibodies, IMM20184 and IMM20190, directly blocked Spike binding to the ACE2 receptor. Binding of the third antibody, IMM20253, to its cryptic epitope on the outer surface of RBD altered the conformation of the Spike Trimer, promoting the release of Spike monomers. These antibodies decreased Omicron SARS-CoV-2 infection in the lungs of Syrian golden hamsters in vivo and potently induced antiviral effector response in vitro, including phagocytosis, ADCC, and complement pathway activation. Our preclinical data demonstrated that the three-antibody cocktail IMM-BCP-01 could be a promising means for preventing or treating infection of SARS-CoV-2 variants of concern, including Omicron BA.1 and BA.2, in susceptible individuals. | |||||||||
History |
|
-Structure visualization
Supplemental images |
---|
-Downloads & links
-EMDB archive
Map data | emd_27081.map.gz | 156.6 MB | EMDB map data format | |
---|---|---|---|---|
Header (meta data) | emd-27081-v30.xml emd-27081.xml | 15.3 KB 15.3 KB | Display Display | EMDB header |
FSC (resolution estimation) | emd_27081_fsc.xml | 11.7 KB | Display | FSC data file |
Images | emd_27081.png | 66.3 KB | ||
Others | emd_27081_half_map_1.map.gz emd_27081_half_map_2.map.gz | 154.4 MB 154.4 MB | ||
Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-27081 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-27081 | HTTPS FTP |
-Validation report
Summary document | emd_27081_validation.pdf.gz | 587.5 KB | Display | EMDB validaton report |
---|---|---|---|---|
Full document | emd_27081_full_validation.pdf.gz | 587.1 KB | Display | |
Data in XML | emd_27081_validation.xml.gz | 20 KB | Display | |
Data in CIF | emd_27081_validation.cif.gz | 25.7 KB | Display | |
Arichive directory | https://ftp.pdbj.org/pub/emdb/validation_reports/EMD-27081 ftp://ftp.pdbj.org/pub/emdb/validation_reports/EMD-27081 | HTTPS FTP |
-Related structure data
-Links
EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
---|
-Map
File | Download / File: emd_27081.map.gz / Format: CCP4 / Size: 166.4 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | IMM20184 and IMM20253 Fabs in complex with SARS-CoV-2 receptor binding domain | ||||||||||||||||||||||||||||||||||||
Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
Voxel size | X=Y=Z: 0.923 Å | ||||||||||||||||||||||||||||||||||||
Density |
| ||||||||||||||||||||||||||||||||||||
Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
Details | EMDB XML:
|
-Supplemental data
-Half map: #2
File | emd_27081_half_map_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: #1
File | emd_27081_half_map_2.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & Slices |
| ||||||||||||
Density Histograms |
-Sample components
-Entire : IMM20184 and IMM20253 Fabs in ternary complex with RBD of SARS-CoV-2
Entire | Name: IMM20184 and IMM20253 Fabs in ternary complex with RBD of SARS-CoV-2 |
---|---|
Components |
|
-Supramolecule #1: IMM20184 and IMM20253 Fabs in ternary complex with RBD of SARS-CoV-2
Supramolecule | Name: IMM20184 and IMM20253 Fabs in ternary complex with RBD of SARS-CoV-2 type: complex / Chimera: Yes / ID: 1 / Parent: 0 |
---|---|
Source (natural) | Organism: Severe acute respiratory syndrome coronavirus |
-Supramolecule #2: IMM20184 Fab
Supramolecule | Name: IMM20184 Fab / type: complex / Chimera: Yes / ID: 2 / Parent: 1 |
---|---|
Source (natural) | Organism: Homo sapiens (human) |
Recombinant expression | Organism: Mammalia (mammals) |
-Supramolecule #3: IMM20253 FAb
Supramolecule | Name: IMM20253 FAb / type: complex / Chimera: Yes / ID: 3 / Parent: 1 |
---|---|
Source (natural) | Organism: Homo sapiens (human) |
Recombinant expression | Organism: Mammalia (mammals) |
-Supramolecule #4: SARS-CoV-2 RBD
Supramolecule | Name: SARS-CoV-2 RBD / type: complex / Chimera: Yes / ID: 4 / Parent: 1 |
---|---|
Source (natural) | Organism: Severe acute respiratory syndrome coronavirus |
Recombinant expression | Organism: Mammalia (mammals) |
-Experimental details
-Structure determination
Method | cryo EM |
---|---|
Processing | single particle reconstruction |
Aggregation state | particle |
-Sample preparation
Buffer | pH: 7.4 |
---|---|
Vitrification | Cryogen name: ETHANE |
-Electron microscopy
Microscope | TFS GLACIOS |
---|---|
Image recording | Film or detector model: FEI FALCON IV (4k x 4k) / Average electron dose: 19.59 e/Å2 |
Electron beam | Acceleration voltage: 200 kV / Electron source: FIELD EMISSION GUN |
Electron optics | Illumination mode: OTHER / Imaging mode: BRIGHT FIELD / Nominal defocus max: 2.5 µm / Nominal defocus min: 1.0 µm |
+Image processing
-Atomic model buiding 1
Refinement | Protocol: RIGID BODY FIT |
---|